Metabiota provides a risk analytics platform that delivers actionable, data-driven insights for countries, governments and corporations to manage and mitigate infectious diseases. Led by founder and CEO Dr. Nathan Wolfe, the company works with local governments, health agencies, private sector firms and non-profit organizations. It has operations in 20 countries and maintains offices in San Francisco, Washington, China, Canada and Sierra Leone. The company intends to use the funds to further develop and deliver epidemic risk management worldwide. Metabiota raised $30m in funding in this round. The round was led by RSTP with participation from multiple strategic and venture investors.

Total raised

$30M

Funding rounds

1

Latest round

Series A

Latest activity

May 2015